Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

Journal of Clinical Oncology

Volumn 9, Issue 3, 1991, Pages 389-393

  Markman, Maurie ^a   Rothman, Robert ^b   Hakes, Thomas ^b   Reichman, Bonnie ^b   Hoskins, William ^b   Rubin, Stephen ^b   Jones, Walter ^b   Almadrones, Lois ^b   Lewis Jr , John L ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN; MIDDLE AGE; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026086870     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.3.389     Document Type: Article

References (23)

1. Hainsworth JD, Grosh WW, Burnett LS, et al: Advanced ovarian cancer: Long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration. Ann Intern Med 108:165-170, 1988
2. Neijt JP, ten Bokkel Huinink WW, van der Burg MEL, et al: Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma. J Clin Oncol 5:1157-1168, 1987
3. Omura GA, Bundy BN, Berek JS, et al: Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 7:457-465, 1989
4. Louie KG, Ozols RF, Myers CE, et al: Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. J Clin Oncol 4:1579-1585, 1986
5. McGuire WP, Rowinsky EK, Rosenshein NB, et al: Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 111:273-279, 1989
6. Stanhope CR, Smith JP, Rutledge F: Second trial drugs in ovarian cancer. Gynecol Oncol 5:52-58, 1977
7. Laufman LR, Green JB, Alberts DS, et al: Chemotherapy of drug-resistant ovarian cancer: A Southwest Oncology Group study. J Clin Oncol 4:1374-1379, 1986
8. Pater JL, Carmichael JA, Krepart GV, et al: Second-line chemotherapy of stage III-IV ovarian carcinoma: A randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin. Cancer Treat Rep 71:277-281, 1987
9. Ozols RF, Young RC: Ovarian cancer. Curr Prob Cancer 11:59-122, 1987
10. Seltzer V, Vogl S, Kaplan B: Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent. Gynecol Oncol 21:167-176, 1985
11. McVie JG, ten Bokkel Huinink WW, Hilton A, et al: Carboplatin and cyclophosphamide in relapsing ovarian cancer patients. Proc Am Soc Clin Oncol 8:161, 1989 (abstr)
12. Reichman B, Markman M, Hakes T, et al: Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian cancer. J Clin Oncol 7:1327-1332, 1989
13. Alberts D, Green S, Hannigan E, et al: Improved efficacy of carboplatin/cyclophosphamide vs cisplatin/cyclophosphamide: Preliminary report of a phase III, randomized trial in stages III-IV, suboptimal ovarian cancer. Proc Am Soc Clin Oncol 8:151, 1989 (abstr)
14. Mangioni C, Bolis G, Pecorelli S, et al: Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin. J Natl Cancer Inst 81:1464-1471, 1989
15. Alberts DS, Mason-Liddil N: Carboplatin in the treatment of ovarian cancer. Semin Oncol 16:19-26, 1989 (suppl 5)
16. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47:207-214, 1981
17. Fisher RI, De Vita VT, Hubbard SP, et al: Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. Ann Intern Med 90:761-763, 1979
18. Batist G, Inde DC, Zabell A, et al: Small-cell carcinoma of the lung: Reinduction therapy after late relapse. Ann Intern Med 98:472-474, 1983
19. Copeland LJ, Gershenson DM: Ovarian cancer recurrences in patients with no macroscopic tumor at second-look laparotomy. Obstet Gynecol 68:873-874, 1986
20. Rubin SC, Hoskins WJ, Hakes TB, et al: Recurrence after negative second-look laparotomy for ovarian cancer: Analysis of risk factors. Am J Obstet Gynecol 159:1094-1098, 1988
21. Markman M, Hakes T, Reichman B, et al: Intraperitoneal therapy in the management of ovarian carcinoma. Yale J Biol Medicine 62:393-403, 1989
22. Dauplat J, Legros M, Condat P, et al: High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation. Gynecol Oncol 34:294-298, 1989
23. Epenetos AA, Munro AJ, Stewart S, et al: Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies. J Clin Oncol 5:1890-1899, 1987